Polyplus extends portfolio designed to support mRNA development 19-Sep-2022 By Jane Byrne Polyplus, a French supplier focused on advanced biologic and cell and gene therapy production, is continuing to build out its mRNA support portfolio.
Yposkesi leveraging expertise of major shareholder, new facility build on schedule 25-Jan-2022 By Jane Byrne The construction of Yposkesi’s second facility is on track, the French CDMO has confirmed.
Special Edition: Meeting demand for viral vectors Polyplus launches transfection reagent for large scale viral vector production 18-Aug-2021 By Jane Byrne Recombinant adeno-associated viruses (rAAVs) are becoming the vector of choice for delivering gene therapies, says the French firm.
